Cargando…
P867: CT103A, A NOVEL FULLY HUMAN BCMA-TARGETING CAR-T CELLS IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA: UPDATED RESULTS OF PHASE 1B/2 STUDY (FUMANBA-1)
Autores principales: | , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10431138/ http://dx.doi.org/10.1097/01.HS9.0000970372.45392.b8 |
_version_ | 1785091129743507456 |
---|---|
author | LI, Chunrui Wang, DI Song, Yongping Huang, He LI, Jianyong Chen, Bing Liu, Jing Dong, Yujun Hu, Kai Liu, Peng Zhang, XI MI, Jianqing LI, Zhenyu Ding, Kaiyang Xu, Aining Cai, Songbai Guo, Jingjing Gui, Hongyu Wang, Wen Qiu, Lugui |
author_facet | LI, Chunrui Wang, DI Song, Yongping Huang, He LI, Jianyong Chen, Bing Liu, Jing Dong, Yujun Hu, Kai Liu, Peng Zhang, XI MI, Jianqing LI, Zhenyu Ding, Kaiyang Xu, Aining Cai, Songbai Guo, Jingjing Gui, Hongyu Wang, Wen Qiu, Lugui |
author_sort | LI, Chunrui |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-10431138 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-104311382023-08-17 P867: CT103A, A NOVEL FULLY HUMAN BCMA-TARGETING CAR-T CELLS IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA: UPDATED RESULTS OF PHASE 1B/2 STUDY (FUMANBA-1) LI, Chunrui Wang, DI Song, Yongping Huang, He LI, Jianyong Chen, Bing Liu, Jing Dong, Yujun Hu, Kai Liu, Peng Zhang, XI MI, Jianqing LI, Zhenyu Ding, Kaiyang Xu, Aining Cai, Songbai Guo, Jingjing Gui, Hongyu Wang, Wen Qiu, Lugui Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10431138/ http://dx.doi.org/10.1097/01.HS9.0000970372.45392.b8 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
spellingShingle | Posters LI, Chunrui Wang, DI Song, Yongping Huang, He LI, Jianyong Chen, Bing Liu, Jing Dong, Yujun Hu, Kai Liu, Peng Zhang, XI MI, Jianqing LI, Zhenyu Ding, Kaiyang Xu, Aining Cai, Songbai Guo, Jingjing Gui, Hongyu Wang, Wen Qiu, Lugui P867: CT103A, A NOVEL FULLY HUMAN BCMA-TARGETING CAR-T CELLS IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA: UPDATED RESULTS OF PHASE 1B/2 STUDY (FUMANBA-1) |
title | P867: CT103A, A NOVEL FULLY HUMAN BCMA-TARGETING CAR-T CELLS IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA: UPDATED RESULTS OF PHASE 1B/2 STUDY (FUMANBA-1) |
title_full | P867: CT103A, A NOVEL FULLY HUMAN BCMA-TARGETING CAR-T CELLS IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA: UPDATED RESULTS OF PHASE 1B/2 STUDY (FUMANBA-1) |
title_fullStr | P867: CT103A, A NOVEL FULLY HUMAN BCMA-TARGETING CAR-T CELLS IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA: UPDATED RESULTS OF PHASE 1B/2 STUDY (FUMANBA-1) |
title_full_unstemmed | P867: CT103A, A NOVEL FULLY HUMAN BCMA-TARGETING CAR-T CELLS IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA: UPDATED RESULTS OF PHASE 1B/2 STUDY (FUMANBA-1) |
title_short | P867: CT103A, A NOVEL FULLY HUMAN BCMA-TARGETING CAR-T CELLS IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA: UPDATED RESULTS OF PHASE 1B/2 STUDY (FUMANBA-1) |
title_sort | p867: ct103a, a novel fully human bcma-targeting car-t cells in patients with relapsed/refractory multiple myeloma: updated results of phase 1b/2 study (fumanba-1) |
topic | Posters |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10431138/ http://dx.doi.org/10.1097/01.HS9.0000970372.45392.b8 |
work_keys_str_mv | AT lichunrui p867ct103aanovelfullyhumanbcmatargetingcartcellsinpatientswithrelapsedrefractorymultiplemyelomaupdatedresultsofphase1b2studyfumanba1 AT wangdi p867ct103aanovelfullyhumanbcmatargetingcartcellsinpatientswithrelapsedrefractorymultiplemyelomaupdatedresultsofphase1b2studyfumanba1 AT songyongping p867ct103aanovelfullyhumanbcmatargetingcartcellsinpatientswithrelapsedrefractorymultiplemyelomaupdatedresultsofphase1b2studyfumanba1 AT huanghe p867ct103aanovelfullyhumanbcmatargetingcartcellsinpatientswithrelapsedrefractorymultiplemyelomaupdatedresultsofphase1b2studyfumanba1 AT lijianyong p867ct103aanovelfullyhumanbcmatargetingcartcellsinpatientswithrelapsedrefractorymultiplemyelomaupdatedresultsofphase1b2studyfumanba1 AT chenbing p867ct103aanovelfullyhumanbcmatargetingcartcellsinpatientswithrelapsedrefractorymultiplemyelomaupdatedresultsofphase1b2studyfumanba1 AT liujing p867ct103aanovelfullyhumanbcmatargetingcartcellsinpatientswithrelapsedrefractorymultiplemyelomaupdatedresultsofphase1b2studyfumanba1 AT dongyujun p867ct103aanovelfullyhumanbcmatargetingcartcellsinpatientswithrelapsedrefractorymultiplemyelomaupdatedresultsofphase1b2studyfumanba1 AT hukai p867ct103aanovelfullyhumanbcmatargetingcartcellsinpatientswithrelapsedrefractorymultiplemyelomaupdatedresultsofphase1b2studyfumanba1 AT liupeng p867ct103aanovelfullyhumanbcmatargetingcartcellsinpatientswithrelapsedrefractorymultiplemyelomaupdatedresultsofphase1b2studyfumanba1 AT zhangxi p867ct103aanovelfullyhumanbcmatargetingcartcellsinpatientswithrelapsedrefractorymultiplemyelomaupdatedresultsofphase1b2studyfumanba1 AT mijianqing p867ct103aanovelfullyhumanbcmatargetingcartcellsinpatientswithrelapsedrefractorymultiplemyelomaupdatedresultsofphase1b2studyfumanba1 AT lizhenyu p867ct103aanovelfullyhumanbcmatargetingcartcellsinpatientswithrelapsedrefractorymultiplemyelomaupdatedresultsofphase1b2studyfumanba1 AT dingkaiyang p867ct103aanovelfullyhumanbcmatargetingcartcellsinpatientswithrelapsedrefractorymultiplemyelomaupdatedresultsofphase1b2studyfumanba1 AT xuaining p867ct103aanovelfullyhumanbcmatargetingcartcellsinpatientswithrelapsedrefractorymultiplemyelomaupdatedresultsofphase1b2studyfumanba1 AT caisongbai p867ct103aanovelfullyhumanbcmatargetingcartcellsinpatientswithrelapsedrefractorymultiplemyelomaupdatedresultsofphase1b2studyfumanba1 AT guojingjing p867ct103aanovelfullyhumanbcmatargetingcartcellsinpatientswithrelapsedrefractorymultiplemyelomaupdatedresultsofphase1b2studyfumanba1 AT guihongyu p867ct103aanovelfullyhumanbcmatargetingcartcellsinpatientswithrelapsedrefractorymultiplemyelomaupdatedresultsofphase1b2studyfumanba1 AT wangwen p867ct103aanovelfullyhumanbcmatargetingcartcellsinpatientswithrelapsedrefractorymultiplemyelomaupdatedresultsofphase1b2studyfumanba1 AT qiulugui p867ct103aanovelfullyhumanbcmatargetingcartcellsinpatientswithrelapsedrefractorymultiplemyelomaupdatedresultsofphase1b2studyfumanba1 |